✦ LIBER ✦

Emerging microtechnologies for the development of oral drug delivery devices

✍ Scribed by Hariharasudhan D. Chirra; Tejal A. Desai

Book ID: 119182687
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 945 KB
Volume: 64
Category: Article
ISSN: 0169-409X
DOI: 10.1016/j.addr.2012.08.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of Anticandidal Delivery Sys

Development of Anticandidal Delivery Systems: (II) Mucoadhesive Devices for Prolonged Drug Delivery in the Oral Cavity

✍ Nair, Mona K.; Chien, Yie W. 📂 Article 📅 1996 🏛 Informa plc 🌐 English ⚖ 858 KB

Lipid – An emerging platform for oral de

Lipid – An emerging platform for oral delivery of drugs with poor bioavailability

✍ Subhashis Chakraborty; Dali Shukla; Brahmeshwar Mishra; Sanjay Singh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 530 KB

Development and characterization of anio

Development and characterization of anionic liposaccharides for enhanced oral drug delivery

✍ Adel S. Abdelrahim; Pavla Simerska; Istvan Toth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 768 KB

Emerging micro- and nanotechnologies at

Emerging micro- and nanotechnologies at the interface of engineering, science, and medicine for the development of novel drug delivery devices and systems

✍ Yogesh Gianchandani; Ellis Meng 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Application ofIn SituPolymerization for

Application ofIn SituPolymerization for Design and Development of Oral Drug Delivery Systems

✍ Ndidi Ngwuluka 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 403 KB

Development and in vivo evaluation of an

Development and in vivo evaluation of an oral drug delivery system for paclitaxel

✍ Javed Iqbal; Federica Sarti; Glen Perera; Andreas Bernkop-Schnürch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 221 KB

The aim of the present study was to investigate the effect of poly(acrylic acid)-cysteine (PAA-cysteine) exhibiting a molecular mass of 100 and 250 kDa and reduced glutathione (GSH) on the absorption of the P-glycoprotein (P-gp) and cytochrome P450 (CYP450) substrate paclitaxel in vitro and in vivo.